Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 16, 2022 02:00 ET | Source: SOM Biotech

SOM Biotech signs licensing agreement with the University of Minnesota

SOM Biotech signs licensing agreement with the University of Minnesota Barcelona, Spain, 16 May 2022. SOM Biotech (“SOM” or the “Company”), a clinical-stage biopharmaceutical company with a...
December 15, 2021 02:00 ET | Source: SOM Biotech

SOM Biotech signs letter of intent with Megapharm to commercialize SOM3355 in Israel and the Palestinian Authority

SOM Biotech signs letter of intent with Megapharm to commercialize SOM3355 in Israel and the Palestinian Authority Barcelona, Spain, 15 December 2021. SOM Biotech (“SOM” or the “Company”), a...
October 18, 2021 01:00 ET | Source: SOM Biotech

SOM Biotech granted Orphan Drug Designation by the FDA for SOM3355

SOM Biotech granted Orphan Drug Designation by the FDA for SOM3355 ~SOM3355 has potential to be an alternative to current VMAT2 inhibitors with a significantly improved side effect profile for the...
October 04, 2021 01:00 ET | Source: SOM Biotech

SOM Biotech presents positive Phase 2a data with SOM3355 at the 34th ECNP Congress 2021

SOM Biotech presents positive Phase 2a data with SOM3355 at the 34th ECNP Congress 2021 ~Data show SOM3355 reduces chorea in patients with Huntingdon’s Disease and has a good safety profile~ ...